Ahearn JM - Search Results

1

Binding of human immunodeficiency virus type 1 to the C3b/C4b receptor CR1 (CD35) and red blood cells in the presence of envelope-specific antibodies and complement. National Institutes of Health AIDS Vaccine Clinical Trials Networks.

Montefiori DC, Graham BS, Zhou JY, Zhou JT, Ahearn JM. Montefiori DC, et al. Among authors: ahearn jm. J Infect Dis. 1994 Aug;170(2):429-32. doi: 10.1093/infdis/170.2.429. J Infect Dis. 1994. PMID: 8035031

2

Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21).

Montefiori DC, Stewart K, Ahearn JM, Zhou J, Zhou J. Montefiori DC, et al. Among authors: ahearn jm. J Virol. 1993 May;67(5):2699-706. doi: 10.1128/JVI.67.5.2699-2706.1993. J Virol. 1993. PMID: 8474169 Free PMC article.

3

Mapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitor.

Kalli KR, Hsu PH, Bartow TJ, Ahearn JM, Matsumoto AK, Klickstein LB, Fearon DT. Kalli KR, et al. Among authors: ahearn jm. J Exp Med. 1991 Dec 1;174(6):1451-60. doi: 10.1084/jem.174.6.1451. J Exp Med. 1991. PMID: 1836011 Free PMC article.

4

Epstein-Barr virus (EBV) infection of murine L cells expressing recombinant human EBV/C3d receptor.

Ahearn JM, Hayward SD, Hickey JC, Fearon DT. Ahearn JM, et al. Proc Natl Acad Sci U S A. 1988 Dec;85(23):9307-11. doi: 10.1073/pnas.85.23.9307. Proc Natl Acad Sci U S A. 1988. PMID: 2848261 Free PMC article.

5

Viral complement regulatory proteins.

Rosengard AM, Ahearn JM. Rosengard AM, et al. Among authors: ahearn jm. Immunopharmacology. 1999 May;42(1-3):99-106. doi: 10.1016/s0162-3109(99)00012-0. Immunopharmacology. 1999. PMID: 10408371 Review.

6

Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex.

Tuveson DA, Ahearn JM, Matsumoto AK, Fearon DT. Tuveson DA, et al. Among authors: ahearn jm. J Exp Med. 1991 May 1;173(5):1083-9. doi: 10.1084/jem.173.5.1083. J Exp Med. 1991. PMID: 1708808 Free PMC article.

7

Complement receptor type 1 (C3b/C4b receptor; CD35) and complement receptor type 2 (C3d/Epstein-Barr virus receptor; CD21).

Fearon DT, Ahearn JM. Fearon DT, et al. Among authors: ahearn jm. Curr Top Microbiol Immunol. 1990;153:83-98. doi: 10.1007/978-3-642-74977-3_5. Curr Top Microbiol Immunol. 1990. PMID: 2153507 Review. No abstract available.

8

Determination of the role for CD21 during Epstein-Barr virus infection of B-lymphoblastoid cells.

Martin DR, Marlowe RL, Ahearn JM. Martin DR, et al. Among authors: ahearn jm. J Virol. 1994 Aug;68(8):4716-26. doi: 10.1128/JVI.68.8.4716-4726.1994. J Virol. 1994. PMID: 7913508 Free PMC article.

9

Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen.

Ahearn JM, Fischer MB, Croix D, Goerg S, Ma M, Xia J, Zhou X, Howard RG, Rothstein TL, Carroll MC. Ahearn JM, et al. Immunity. 1996 Mar;4(3):251-62. doi: 10.1016/s1074-7613(00)80433-1. Immunity. 1996. PMID: 8624815 Free article.

10

Functional characterization of soluble and membrane-bound forms of vaccinia virus complement control protein (VCP).

Rosengard AM, Alonso LC, Korb LC, Baldwin WM 3rd, Sanfilippo F, Turka LA, Ahearn JM. Rosengard AM, et al. Among authors: ahearn jm. Mol Immunol. 1999 Jul;36(10):685-97. doi: 10.1016/s0161-5890(99)00081-4. Mol Immunol. 1999. PMID: 10509819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters